| Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer WJ Kim, EJ Kim, SK Kim, YJ Kim, YS Ha, P Jeong, MJ Kim, SJ Yun, ... Molecular cancer 9, 1-9, 2010 | 356 | 2010 |
| Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer SJ Yun, P Jeong, WT Kim, TH Kim, YS Lee, PH Song, YH Choi, IY Kim, ... International journal of oncology 41 (5), 1871-1878, 2012 | 175 | 2012 |
| Diagnosis of bladder cancer and prediction of survival by urinary metabolomics X Jin, SJ Yun, P Jeong, IY Kim, WJ Kim, S Park Oncotarget 5 (6), 1635, 2014 | 153 | 2014 |
| Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence SC Lee, YJ Kim, TH Kim, SJ Yun, NK Lee, WJ Kim The Journal of urology 179 (2), 570-574, 2008 | 125 | 2008 |
| Role of the epithelial-mesenchymal transition in bladder cancer: from prognosis to therapeutic target SJ Yun, WJ Kim Korean journal of urology 54 (10), 645, 2013 | 105 | 2013 |
| Schisandrin A suppresses lipopolysaccharide-induced inflammation and oxidative stress in RAW 264.7 macrophages by suppressing the NF-κB, MAPKs and PI3K/Akt pathways and … DH Kwon, HJ Cha, EO Choi, SH Leem, GY Kim, SK Moon, YC Chang, ... International Journal of Molecular Medicine 41 (1), 264-274, 2018 | 100 | 2018 |
| Downregulation of cell‐free miR‐198 as a diagnostic biomarker for lung adenocarcinoma‐associated malignant pleural effusion HS Han, J Yun, S Lim, JH Han, KH Lee, ST Kim, MH Kang, SM Son, ... International journal of cancer 133 (3), 645-652, 2013 | 95 | 2013 |
| Natural history of asymptomatic renal stones and prediction of stone related events HW Kang, SK Lee, WT Kim, YJ Kim, SJ Yun, SC Lee, WJ Kim The Journal of urology 189 (5), 1740-1746, 2013 | 80 | 2013 |
| A four-gene signature predicts disease progression in muscle invasive bladder cancer WJ Kim, SK Kim, P Jeong, SJ Yun, IC Cho, IY Kim, SK Moon, HD Um, ... Molecular Medicine 17, 478-485, 2011 | 74 | 2011 |
| Cell-free microRNA-214 from urine as a biomarker for non-muscle-invasive bladder cancer SM Kim, HW Kang, WT Kim, YJ Kim, SJ Yun, SC Lee, WJ Kim Korean journal of urology 54 (11), 791, 2013 | 73 | 2013 |
| Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A SJ Lee, EJ Lee, SK Kim, P Jeong, YH Cho, SJ Yun, S Kim, GY Kim, ... PloS one 7 (9), e40267, 2012 | 67 | 2012 |
| PFKFB4 as a prognostic marker in non-muscle-invasive bladder cancer SJ Yun, SW Jo, YS Ha, OJ Lee, WT Kim, YJ Kim, SC Lee, WJ Kim Urologic Oncology: Seminars and Original Investigations 30 (6), 893-899, 2012 | 61 | 2012 |
| Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of … SJ Kim, JS Kim, SW Kim, E Brantley, SJ Yun, J He, M Maya, F Zhang, ... Neoplasia 13 (2), 167-IN12, 2011 | 56 | 2011 |
| Anti-proliferative and pro-apoptotic effects of Licochalcone A through ROS-mediated cell cycle arrest and apoptosis in human bladder cancer cells SH Hong, HJ Cha, H Hwang-Bo, MY Kim, SY Kim, SY Ji, JH Cheong, ... International journal of molecular sciences 20 (15), 3820, 2019 | 55 | 2019 |
| Expectant management of ureter stones: outcome and clinical factors of spontaneous passage in a single institution's experience DU Tchey, YS Ha, WT Kim, SJ Yun, SC Lee, WJ Kim Korean journal of urology 52 (12), 847, 2011 | 54 | 2011 |
| Prostate size correlates with fasting blood glucose in non-diabetic benign prostatic hyperplasia patients with normal testosterone levels WT Kim, SJ Yun, YD Choi, GY Kim, SK Moon, YH Choi, IY Kim, WJ Kim Journal of Korean medical science 26 (9), 1214, 2011 | 52 | 2011 |
| Urinary microRNAs of prostate cancer: virus-encoded hsv1-miRH18 and hsv2-miR-H9-5p could be valuable diagnostic markers SJ Yun, P Jeong, HW Kang, YH Kim, EA Kim, C Yan, YK Choi, D Kim, ... International neurourology journal 19 (2), 74, 2015 | 50 | 2015 |
| TOX-expressing terminally exhausted tumor-infiltrating CD8+ T cells are reinvigorated by co-blockade of PD-1 and TIGIT in bladder cancer HS Han, S Jeong, H Kim, HD Kim, AR Kim, M Kwon, SH Park, CG Woo, ... Cancer letters 499, 137-147, 2021 | 49 | 2021 |
| Role of exosomal miRNA in bladder cancer: a promising liquid biopsy biomarker XM Piao, EJ Cha, SJ Yun, WJ Kim International journal of molecular sciences 22 (4), 1713, 2021 | 45 | 2021 |
| Expression levels of FGFR3 as a prognostic marker for the progression of primary pT1 bladder cancer and its association with mutation status HW Kang, YH Kim, P Jeong, C Park, WT Kim, DH Ryu, EJ Cha, YS Ha, ... Oncology Letters 14 (3), 3817-3824, 2017 | 45 | 2017 |
